Fitterfly is a healthtech startup operating in the digital health and therapeutics space. The article identifies the company’s sector but provides no product-level detail or customer metrics. On Wednesday, Fitterfly announced it raised $12 million in a Series A funding round. The report does not disclose participating investors, valuation, or use of proceeds. The article also omits operating metrics such as revenue or user numbers, and it does not mention founding year or headquarters. No future plans or roadmap were described in the coverage. Fitterfly provides personalized digital therapeutics (DTx) programmes that work complementary to doctors’ medical therapy and offer 360-degree guidance on nutrition, exercise, sleep, stress, and other factors affecting health outcomes. Its product portfolio currently targets diabetes, pregnancy, PCOS, and obesity. The company has a team of more than 140 members including senior doctors, nutritionists, psychologists, fitness experts, and technologists. More than 10,000 people have subscribed to and benefited from Fitterfly’s programmes. Fitterfly plans to expand its DTx portfolio and invest in developing AI and smart health-tracking tools to enable more personalized, human-centric treatments. The company says it will use funding to improve its solution to deliver better patient outcomes at scale and to increase awareness and reach.

Total raised

$15M

Funding rounds

2

Latest round

Series A

Latest activity

Jul 2022